Literature DB >> 9811503

Attachment of degradable poly(ethylene glycol) to proteins has the potential to increase therapeutic efficacy.

M J Roberts1, J M Harris.   

Abstract

Capillary electrophoresis (CE) was investigated for characterizing poly(ethylene glycol) (PEG) attachment ("PEGylation") and PEG removal ("dePEGylation") of proteins. Lysozyme was used as a model protein because it is one of the best understood enzymes, has a high ionic strength (high pI value; thus making it suitable for CE), and has a tertiary structure that is known with high resolution. Several PEG derivatives, both hydrolytically degradable and nondegradable and with varying reactivities toward amino groups, were used to couple to amino groups (six epsilon-amino and one alpha-amino) on the surface of the protein. Capillary electrophoresis was found to be useful in following both the PEGylation and dePEGylation of lysozyme. Capillary electrophoresis separation is based on the size of the conjugate, which is determined by the number and molecular weight of the PEG that is attached. Baseline resolution was obtained between the peaks for each PEG chain attached per protein molecule ("PEGmers") for PEG molecular weights >5000, although individual PEGmers could be recognized at lower molecular weights without baseline separation. Highly modified lysozyme showed complete inactivation, but when released from the degradable PEG, regained >60% of the original in vitro activity. The sites of PEGylation were determined using a tryptic map of the modified and unmodified protein. Typically, peptide fragments are separated by reversed-phase HPLC, but we show that CE can provide a complementary separation technique for determining sites of PEGylation. Capillary electrophoresis has advantages of high efficiency separations, rapid analysis, and ease of use.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811503     DOI: 10.1021/js9800634

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Degradable PEGylated Protein Conjugates Utilizing RAFT Polymerization.

Authors:  Caitlin G Decker; Heather D Maynard
Journal:  Eur Polym J       Date:  2015-04-01       Impact factor: 4.598

2.  The effect of two different polyethylene glycol (PEG) derivatives on the immunological response of PEG grafted pancreatic islets.

Authors:  Hamideh Aghajani-Lazarjani; Ebrahim Vasheghani-Farahani; Seyed Abbas Shojaosadati; Sameereh Hashemi-Najafabadi; Saleh Zahediasl; Taki Tiraihi; Fatemeh Atyabi
Journal:  J Artif Organs       Date:  2010-12-04       Impact factor: 1.731

3.  Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS.

Authors:  Xiaojun Lu; P Clayton Gough; Michael R DeFelippis; Lihua Huang
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-25       Impact factor: 3.109

Review 4.  To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Authors:  Da Shi; Damian Beasock; Adam Fessler; Janos Szebeni; Julia Y Ljubimova; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2021-12-10       Impact factor: 15.470

5.  Toward top-down determination of PEGylation site using MALDI in-source decay MS analysis.

Authors:  Chul Yoo; Detlev Suckau; Volker Sauerland; Michael Ronk; Minhui Ma
Journal:  J Am Soc Mass Spectrom       Date:  2008-11-01       Impact factor: 3.109

Review 6.  Delivery of therapeutic proteins.

Authors:  Dipak S Pisal; Matthew P Kosloski; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2010-06       Impact factor: 3.534

7.  Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC).

Authors:  Sam-Mui Tsui; Wai-Man Lam; Tin-Lun Lam; Hiu-Chi Chong; Pui-Kin So; Sui-Yi Kwok; Simon Arnold; Paul Ning-Man Cheng; Denys N Wheatley; Wai-Hung Lo; Yun-Chung Leung
Journal:  Cancer Cell Int       Date:  2009-04-17       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.